Jump to content

Biomet

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Wuerzele (talk | contribs) at 04:35, 23 February 2015 (Biomet Microfixation: added more detail and refs from company). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Biomet, Inc.
Company typePrivate
IndustryHealth Care
FoundedWarsaw, IN, USA (1977)
HeadquartersWarsaw, IN, USA
Key people
Jeff Binder, CEO
ProductsOxford Partial Knee, LactoSorb
OwnerBlackstone Group, Goldman Sachs, Kohlberg Kravis Roberts, TPG Capital
Number of employees
9,200 (2007)
Websitewww.biomet.com

Biomet, Inc. is one of the world's leading medical device manufacturers located in the Warsaw, Indiana business cluster.[1] The company specializes in reconstructive products for hips, knees and shoulders, fixation devices, orthopedic support devices, dental implants, spinal implants and operating room supplies.

In April 2014, it was announced that Zimmer Holdings had succeeded in a bid to acquire Biomet for a fee of $13.4 billion. However in October 2014, EU antitrust regulators opened an investigation into Zimmer’s bid on the grounds that the deal may lead to substantial decreases in competition in certain markets. [2] The verdict of the investigation into the deal that would make Zimmer the world's second-largest seller of orthopaedic products behind Johnson & Johnson is expected on 26 May 2015.[3]

History

Biomet 2 was established in 1977 and delivered its first hip replacement in 1978. In a September 2007 club deal, the company was acquired by a consortium of private equity firms and ceased trading on NASDAQ.[4] The four founders of Biomet were: Dane A. Miller, Ray Harroff, Niles Noblitt, and Jerry Ferguson.[citation needed]

Biomet Microfixation

Biomet Microfixation is a subsidiary of Biomet[citation needed] As of 2015 Biomet Microfixation manufactures mainly craniomaxillofacial and neurosurgical products[5] These include LactoSorb, a fixation system made of completely resorbable material for guided bone regeneration, titanium plates and screws for craniomaxillofacial fixation, instruments for craniomaxillofacial and orthopedic procedures and hard tissue replacements made out of biocompatible polymers, as used in cranial defects. Biomet has used polymethylmethacrylate (PMMA) beads, which are fused together with polyhydroxyethylmethacrylate (PHEMA) for cranial plates since 1993.[6]: 4  The other material is polyetherketoneketone (PEKK) formed either by laser sintering or by 3D printing.[7]

References

  1. ^ Hermann Simon mentioned this company in his correspondent Book as an example of a "Hidden Champion" (Simon, Hermann: Hidden Champions of the 21st Century : Success Strategies of unknown World Market Leaders. London: Springer, 2009.- ISBN 978-0-387-98147-5.)
  2. ^ "EU regulators open extensive probe into Zimmer, Biomet deal" (Press release). Reuters. 3 October 2014.
  3. ^ "EU regulators set new May 26 deadline for Zimmer's Biomet deal" (Press release). Reuters. Feb 10, 2015.
  4. ^ http://www.biomet.com/corporate/investors/biometAcquired.cfm Biomet acquired by Private Equity Consortium (Biomet)September 25, 2007
  5. ^ Biomet Microfixation (Biomet) n.d.
  6. ^ "HTR-PMMA Patient-Matched Implant". Biomet. August 2013. p. 12. Retrieved 23 February 2015.
  7. ^ "Neurosurgery Solutions: HTR-PEKK Patient-Matched Cranial Implant". Biomet. n.d. Retrieved 23 February 2015.